A2 Milk could benefit as Abbott pulls out of Chinese infant formula market

A2 Milk could benefit as Abbott pulls out of Chinese infant formula market
The US company's market share in China will be up for grabs. (Image: Getty)
Rebecca Howard
A2 Milk stands to benefit as US-based healthcare firm Abbott Laboratories phases out its infant and child nutrition business in China, but the news also underscores how tough that market is.Abbott will gradually stop making and selling baby formula under the Eleva, PediaSure, and Similac brands as well as the sub-brands of Total Comfort and NeoSure, it said on WeChat, according to news service Yicai Global.In the English translation of an internal email seen by BusinessDesk, company executives said it was a “difficult decision” that...

More Primary Sector

Bremworth getting back into synthetics
Primary Sector

Bremworth getting back into synthetics

Albeit in a small, but carefully curated, number of products.

Agriculture the winner in senior science advisory roles
Primary Sector

Agriculture the winner in senior science advisory roles

The Science & Technology Advisory Council is weighted towards the dairy industry.

Greg Hurrell 08 May 2025
Bremworth's Greg Smith’s next chapter
Primary Sector

Bremworth's Greg Smith’s next chapter

His exit was a consequence of the boardroom coup.

Riley Kennedy 08 May 2025